354200.KS · 엔젠바이오
South Korea · RS rating 7 · As of 2026-10-14
| Price | 736.00 KRW |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 2 / 40 / 8 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 14 / 41 |
| Industry group (rank) | Medical-Biomed/Biotech (95) |
| EPS growth Q/Q | +20.1% |
| Sales growth Q/Q | +4.2% |
| Distance from 52-week high | +72.1% |
| Market cap (USD) | $9.4M |